This Week’s Roundup Of Vaccine News

Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease Globally recognized biotechnology innovator and distributor,… read more

This Week’s Roundup Of Vaccine News

AZD1222 US Phase III primary analysis confirms safety and efficacy 76% vaccine efficacy against symptomatic COVID-19100% efficacy against severe or critical disease and hospitalisation85% efficacy against symptomatic COVID-19 in participants aged 65 years… read more

en_USEnglish
Open chat
Come chat with us!
Hello! How can I help you?